Lumeris
Lumeris raises $100M Growth at $600M valuation
Quick Facts
Lumeris: Growth Funding Round
Lumeris has successfully raised $100M in Growth funding, reaching a valuation of $600M.
Company Overview
Healthcare spending and value-based care platform
Funding Details
The Growth round was led by Centene Corporation, with participation from Clayton Dubilier & Rice.
Company Information
- Headquarters: St. Louis, MO
- Founded: 2012
- Employees: 500+
- Category: HealthTech
Investment
Lumeris plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Centene Corporation: Verified investor in Growth
- Clayton Dubilier & Rice: Verified investor in Growth
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
